Use of [18F]FECNT in Positron Emission Tomography
NCT00083629 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2008-03-04
Summary
This study will examine the use of a new radioactive tracer called \[18F\]FECNT in positron emission tomography (PET) scanning for measuring dopamine transporter (DAT) in the brain. DAT is found in brain neurons (nerve cells) that release the chemical messenger dopamine. By taking pictures of the DAT, scientists hope to learn more about the function of these neurons.
Normal, healthy volunteers between 18 and 65 years of age may be eligible for this study. Candidates are screened with a medical history and physical examination, psychological assessment, and blood and urine tests.
Subjects enrolled in the study participate in one of the following procedures:
Brain Imaging Study: Part 1
Two catheters (small plastic tubes) are placed into veins in the subject's arms for injecting \[18F\]FECNT and for collecting blood samples during the scan. A third catheter is placed into a wrist artery to obtain arterial blood during the scan. With the catheters in place, the subject lies down on the scanner bed with his or her head placed in a special mask that limits movement during the brain scan. The scan begins with an initial x-ray like picture for about 10 minutes, after which the \[18F\]FECNT is injected and the actual PET scan starts. The entire procedure takes about 6 hours, including 2 hours of continuous scanning sessions, during which the subject is required to lie still. Subjects can relax out of the scanner between scans. They are monitored throughout the procedure. Vital signs are measured and electrocardiogram is taken once before and twice after injection of the tracer. At the end of the scanning, additional blood and urine samples are collected. Subjects are asked to urinate every 2 hours to lessen the radioactivity in the body.
Whole Body Imaging Study: Part 2
For this procedure, a catheter is placed in a vein for injecting the \[18F\]FECNT tracer. A total of five scans are taken, each one spanning from head to upper thigh. During the course of the scans, x-ray like pictures are obtained. The first scan takes about 100 minutes. Four additional 1-hour scans are done every 100 minutes. The total time for the scans is about 6 hours, and the total time for the entire procedure is about 9 hours. About 2 tablespoons of blood are drawn by needle stick at one time during the imaging. Subjects can leave the PET scanner between scans. They are asked to urinate every 2 hours for 6 hours from the time of tracer injection and to collect all the urine so that radioactivity can be measured.
Brain Imaging Study: Part 3
Part 3 of the study is the same as Part 1, except that two PET procedures are done on separate days, the second within 4 weeks of the first. In addition, participants may also under magnetic resonance imaging (MRI) scanning, a test that uses magnetic fields and radio waves to obtain pictures of the brain.
Conditions
- Healthy
Interventions
- PROCEDURE
-
PET
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
lead NIH
Study Design
- Purpose
- TREATMENT
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-05-31
- Completion
- 2005-09-30
Countries
- United States
Study Locations
More Related Trials
-
Brain Imaging of Serotonin Transporters in the Brain
NCT00059046 ·Status: COMPLETED
-
PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB
NCT00527579 ·Status: COMPLETED ·Phase: PHASE1
-
Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
NCT05357612 ·Status: RECRUITING ·Phase: PHASE4
-
Striatal and Extra-striatal Dopamine Release in Response to Food in Healthy Humans
NCT02310360 ·Status: ACTIVE_NOT_RECRUITING
-
Dopamine Receptor Imaging in Mood Disorders
NCT00116077 ·Status: COMPLETED
-
Neuroimaging Studies of Reward Processing in Depression
NCT03026036 ·Status: COMPLETED
-
Serotonin Transporters in Obsessive-Compulsive-Related Disorders
NCT00082550 ·Status: COMPLETED
-
The Impact of Reward-induced Dopamine Release on Functional Connectivity: a Combined PET/fMRI Study
NCT02801643 ·Status: COMPLETED
-
PET Imaging of Brain 5-HT(1A) Receptors Using [(11)C](-)-RWAY
NCT00263523 ·Status: COMPLETED ·Phase: PHASE1
-
I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal Volunteers
NCT00001771 ·Status: COMPLETED
-
Effect of Direct Current Polarization on Brain Function
NCT00088569 ·Status: COMPLETED
-
Normal Brain Imaging Database for Brain Disorder Studies
NCT03027869 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Reliability of the Human Brain Connectome
NCT02193425 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
PET Imaging of Brain mGluR1 Receptors Using [18F]FIMX
NCT02230592 ·Status: COMPLETED
-
Evaluation of a Novel Positron Emission Tomography (PET Radiotracer for TARP Gamma-8
NCT02108015 ·Status: TERMINATED ·Phase: PHASE1
-
Dosimetry of [11C]CHDI-180R and [11C]CHDI-626.
NCT05224115 ·Status: COMPLETED
-
Investigating Electroencephalographic Predictors of Default Mode Network Anticorrelation in Healthy Adults
NCT05592600 ·Status: COMPLETED ·Phase: NA
-
SV2 PET Imaging With [11C]APP311
NCT03995121 ·Status: RECRUITING
-
Targeting Large-scale Networks in Depression With Real-time fMRI (Functional Magnetic Resonance Imaging) Neurofeedback
NCT05934604 ·Status: COMPLETED ·Phase: NA
-
Measuring the Latency Connectome in the Central Nervous Systems Using Neuroimaging and Neurophysiological Techniques
NCT03223636 ·Status: COMPLETED
-
Imaging of Brain Receptors Using (11C)mGlu1
NCT01420952 ·Status: TERMINATED ·Phase: PHASE1
-
Development of Magnetic Resonance Spectroscopic Imaging Techniques for Imaging Metabolites in Human Brain and Muscle
NCT01266577 ·Status: RECRUITING ·Phase: NA
-
Imaging Synapses With [11C] UCB-J in the Human Brain
NCT04038840 ·Status: RECRUITING ·Phase: PHASE1
-
Longitudinal SV2A PET and MRI in Premanifest HD
NCT06626412 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.2 (Stress Manipulation)
NCT04325529 ·Status: ACTIVE_NOT_RECRUITING